Effect of Starch Microspheres on the Passage of Labelled Erythrocytes and a Low Molecular Weight Marker Through the Liver

References

• Bevan J. A., Tofe A. J., Benedict J. J., Francis M. D., Barnett B. L. Tc-99m HMDP (hydroxymethylene diphos-phonate. A radiopharmaceutical for skeletal and acute myo-cardial infarct imaging. I. Synthesis and distribution in animals. J. Nucl. Med. 1980; 21: 961
   PubMed Web of Science ®Google Scholar
• Castonovo F. P., Guiberteau M. J., Berg G., McKusic K. A., Callahan R. J., Potsaid M. S. Pharmacokinetics of technetium-99m diphosphonate. J. Nucl. Med. 1977; 18: 809
   PubMed Web of Science ®Google Scholar
• Dahlström J. A., Carlsson S., Lilja B., Mattson S., Pettersson C. Cardiac blood pool imaging. A clinical comparison between red blood cells labelled with 99Tcm in vivo and in vitro and 99Tcm-labelled human serum albumin. J. Nucl. Med. 1979; 18: 271
   Google Scholar
• Dakhil S., Ensminger W. D., Cho K., Niederhuber J., Doan K., Wheeler R. Improved regional selectivity of hepatic arterial BCNU with degradable starch microspheres. Cancer 1982; 50: 631
   PubMed Web of Science ®Google Scholar
• Ensminger W. D., Gyves J. W., Stetson P., Walker-Andrews S. Phase I study of hepatic arterial degradable starch microspheres and mitomycin. Cancer Res. 1985; 45: 4464
   PubMed Web of Science ®Google Scholar
• Gyves J. W., Ensminger W. D., Vanharken D., Niederhuber J., Stetson P., Walker S. Improved regional selectivity of hepatic arterial Mitomycin by starch micro-spheres. Clin. Pharmacol. Ther. 1983; 34: 259
   PubMed Web of Science ®Google Scholar
• Hamilton R. G., Alderson P. O. A comparative evaluation of techniques for rapid and efficient in vivo labeling of red cells with [99Tcm] pertechnetate. J. Nucl. Med. 1977; 18: 1008
   Web of Science ®Google Scholar
• Lindell B., Aronson K.-F., Nosslin B., Rothman U. Studies in pharmacokinetics and tolerance of substances temporarily retained in the liver by microsphere embolization. Ann. Surg. 1978; 187: 95
   PubMed Web of Science ®Google Scholar
• Littlefield J. L., Rudd T. G. Tc-99m hydroxymethylene diphosphonate and Tc-99m methylene diphosphonate. Biological and clinical comparison. Concise communication. J. Nucl. Med. 1983; 24: 463
   PubMed Web of Science ®Google Scholar
• Lorelius L., Benedetto A., Blumhardt R., Gaskill H. V., Lancaster J. L., Stridbeck H. Enhanced drug retention in VX2 tumours by use of degradable starch microspheres. Invest. Radiol. 1984; 19: 212
   PubMed Web of Science ®Google Scholar
• Löffler T., Aigner K., Hausamen T. V. Cisplatin, Mitomycin C and 5-FU tissue concentrations in hepatic me-tastases after intra-arterial chemotherapy alone and with use of starch microspheres. Abstract. Am. Assoc. for Cancer Res., Houston 1985
   Google Scholar
• Makler T. P., Jr, Charkes D. N. Studies of skeletal tracer kinetics IV. Optimum time delay for Tc-99m(Sn) methylene diphosphonate bone imaging. J. Nucl. Med. 1980; 21: 641
   PubMed Web of Science ®Google Scholar
• Pavel D. G., Zimmerman A. M., Pattersson V. N. In vivo labeling of red blood cells with 99Tcm. A new approach to blood pool visualization. J. Nucl. Med. 1977; 18: 305
   PubMed Web of Science ®Google Scholar
• Starkhammar H., Håkansson L., Leander E., Svedberg J. Passage of radiolabelled substances into the systemic circulation. A methodological study on the effect of intra-arterially injected starch microspheres., Submitted for publication
   Google Scholar
• Starkhammar H., Håkansson L., Leander Morales E. O., Svedberg J. Intra-arterial Mitomycin C treatment of unresectable liver tumours. Preliminary results on the effect of degradable starch microspheres. Acta Oncol. 1987; 26: 295
   PubMed Web of Science ®Google Scholar
• Starkhammar H., Håkansson L., Leander E. Effect of microspheres in intra-arterial chemotherapy. A study of arterio-venous shunting and passage of a labelled marker. Med. Oncol. & Turn. Pharmacother., Accepted for publication
   Google Scholar
• Starkhammar H., Håkansson L., Leander E., Sjödahl R., Svedberg J., Ekberg S. Effect of portal blood flow and intra-arterially injected starch micro-spheres on the passage of a labelled tracer through the liver. An experimental study in pigs. Acta Oncol. 1987; 26: 217
   PubMed Web of Science ®Google Scholar
• Teder H., Nilsson M., Aronsen K.-F. Gamma camera evaluation of the effects of degradable starch microspheres on arterial liver blood flow in the rat. Res. Exp. Med. 1985; 185: 391
   PubMedGoogle Scholar
• Teder H., Nilsson M., Aronsen K.-F., Jonsson K., Hellekant C, Aspegren K., Aronsen K.-F. Hepatic arterial administration of doxorubicin (adriamycin) with or without degradable starch micro-spheres. A pharmacokinetic study in man. Anthracy-clines and cancer therapy, H. H. Hansen. Excerpta Medica, Amsterdam 1983; 166
   Google Scholar
• Thulin L., Tydén G., Nyberg B., Calissendorff B., Hultcrantz R. Reduction of hepatic arterial flow by degradable starch microspheres in patients with liver tumour. Acta Chir. Scand. 1986; 152: 447
   PubMedGoogle Scholar
• Tuma R. F. The use of degradable starch microspheres for transient occlusion of blood flow and for drug targeting to selected tissue. Microspheres and Drug Therapy. Pharmaceutical, immunological and medical aspects, S. S. Davis, L. Ilium, J. G. Me, E. Vie Tomlinson. Elsevier., Amsterdam 1984; 189
   Google Scholar